Presentations in this session:

14:30 MOAX0101 Powerpoint (272 KB)	Introduction to the topic Ian Wanyeki, Kenya
14:35 MOAX0102 Abstract	The incidence of HIV-associated multicentric Castlemans disease Presented by M Bower, United Kingdom J. Krell1, M. Tuthill1, V. Campbell1, P. Holmes1, G. Panos1, V. Harding1, T. Powles1, S. Mandalia1, M. Bower2 1Chelsea and Westminster Hospital NHS Foundation Trust, HIV Medicine, London, United Kingdom, 2Chelsea and Westminster Hospital NHS Foundation Trust, HIV Medicine & Oncology, London, United Kingdom
14:50 MOAX0103 Abstract Powerpoint (545 KB)	Improvement in healing and reduction on HIV shedding following addition of episodic Acyclovir therapy to the syndromic management of genital ulceration; A randomized controlled trial Presented by Sarah Hawkes, United Kingdom G. Paz-Bailey1, M. Sternberg2, A. Puren3, L. Markowitz2, R. Ballard2, S. Delany4, S. Hawkes5, O. Nwanyanwu6, C. Ryan7, D. Lewis8 1Universidad del Valle de Guatemala, Global AIDS Program for Central America, CDC, Guatemala, Guatemala, 2Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, United States, 3National Institute for Communicable Diseases, Specialized Molecular Diagnostics Unit, Johannesburg, South Africa, 4Reproductive Health Research Unit, University of the Witwatersrand, Johannesburg, South Africa, 5London School of Hygiene and Tropical Medicine, Department of Infectious Diseases, London, United Kingdom, 6Centers for Disease Control and Prevention, Global AIDS Program, South Africa, Johannesburg, South Africa, 7Centers for Disease Control and Prevention, Global AIDS Program, Atlanta, United States, 8National Institute for Communicable Diseases, STI Reference Centre, Johannesburg, South Africa
15:05 MOAX0104 Abstract Powerpoint (849 KB)	Correlation between HIV-1 molecular characteristics and response to HAART in pediatric population from Sao Paulo, Brazil Presented by Luis Brigido C. Oliveira1, R. Rodrigues1, C. Vazquez2, M. Ferrão2, A. Campeas2, S. Marques2, L. Brígido1 1Adolfo Lutz Institute, Virology, São Paulo, Brazil, 2Emilio Ribas Institute, São Paulo, Brazil Luis F.M. Brigido, Brazil
15:20 MOAX0105 Abstract	Evaluation of the impact of HIV-1 genetic diversity subtypes in the antiretroviral therapy efficacy in infected patients in Rio de Janeiro, Brazil: a follow up study Presented by Saada Chequer Fernandez, Brazil S. Chequer Fernandez1, C. Santos Rodrigues2, D. Rufino dos Santos3, J.H. Pilotto4, M. Morgado3 1Oswaldo Cruz Foundation, Immunology, Rio de Janeiro, Brazil, 2Hospital dos Servidores, Rio de Janeiro, Brazil, 3Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 42. Evandro Chagas Clinical Research Institute, Rio de Janeiro, Brazil
15:35 MOAX0106 Abstract	Immune based therapy using gamma interferon (Ingaron) in the treatment of HIV/AIDS patients with active pulmonary tuberculosis (PTB) not previously on HAART Presented by Auwal Yola, Nigeria A. Yola1, T. Sologub2 1Infectious Diseases Hospital, HIV/TB Treatment Centre, Kano, Nigeria, 2St. Petersburg Medical Academy, Department of Infectious Diseases, St. Petersburg, Russian Federation